Journal article
Overexpression of sarcoendoplasmic reticulum calcium ATPase 2a promotes cardiac sympathetic neurotransmission via abnormal endoplasmic reticulum and mitochondria Ca2+ regulation
- Abstract:
- Reduced cardiomyocyte excitation-contraction coupling and downregulation of the sarco-endoplasmic reticulum calcium ATPase 2a (SERCA2a) is associated with heart failure. This has led to viral transgene upregulation of SERCA2a in cardiomyocytes as a treatment. We hypothesized that SERCA2a gene therapy expressed under a similar promiscuous cytomegalovirus promoter could also affect the cardiac sympathetic neural axis and promote sympatho-excitation. Stellate neurons were isolated from 90-120g male, Sprague Dawley (SD), Wistar Kyoto (WKY), and spontaneously hypertensive rats (SHR). Neurons were infected with Ad-mCherry or Ad-mCherry-hATP2Aa (SERCA2a). Intracellular Ca2+ changes were measured using Fura-2AM in response to KCl, caffeine, thapsigargin and FCCP to mobilize intracellular Ca2+ stores. The effect of SERCA2a on neurotransmitter release was measured using 3H-norepinephrine overflow from 340-360g SD rat atria in response to right stellate ganglia stimulation. Upregulation of SERCA2a resulted in greater neurotransmitter release in response to stellate stimulation compared to control (Empty: 98.7±20.5cpm, n=7. SERCA: 186.5±28.41cpm, n=8. *P<0.05). In isolated SD rat stellate neurons SERCA2a overexpression facilitated greater depolarisation induced Ca2+ transients (Empty: 0.64±0.03au, n=57. SERCA: 0.75±0.03au, n=68. *P<0.05), along with increased endoplasmic reticulum and mitochondria Ca2+ load. Similar results were observed in WKY and age matched SHRs despite no further increase in ER load being observed in the SHR (SHR. Empty: 0.16±0.04au, n=18. SERCA: 0.17±0.02au, n=25). In conclusion, SERCA2a upregulation in cardiac sympathetic neurons resulted in increased neurotransmission and increased Ca2+ loading into intracellular stores. Whether the increased Ca2+ transient and neurotransmission following SERCA2A overexpression contributes to enhanced sympathoexcitation in heart failure patients remains to be determined.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.5MB, Terms of use)
-
- Publisher copy:
- 10.1161/HYPERTENSIONAHA.116.08507
Authors
- Publisher:
- American Heart Association
- Journal:
- Hypertension More from this journal
- Volume:
- 69
- Issue:
- 4
- Pages:
- 625-632
- Publication date:
- 2017-01-01
- Acceptance date:
- 2017-01-19
- DOI:
- EISSN:
-
1524-4563
- ISSN:
-
0194-911X
- Keywords:
- Pubs id:
-
pubs:677696
- UUID:
-
uuid:4a49bfeb-eebe-45d7-98a9-25e98d4a6013
- Local pid:
-
pubs:677696
- Deposit date:
-
2017-02-08
- ARK identifier:
Terms of use
- Copyright holder:
- Shanks et al
- Copyright date:
- 2017
- Notes:
-
Copyright
© 2017 The Authors.
Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record